The Global Bioidentical Hormones Market is estimated to be USD 340.6 Mn in 2021 and is expected to reach USD 826.54 Mn by 2026, growing at a CAGR of 19.40%.
Market Dynamics
The increasing government initiatives towards the health sector, the rising level of screening of hormonal deficiency, and growing healthcare expenditure have prompted the demand of the bioidentical hormones market. In addition, the increasing geriatric population, rising awareness, and focus on female healthcare have escalated the market growth. According to a study conducted by researchers from the Obstetrics and Gynaecology Department of Kafkas University in January 2019, nearly 432 females out of 926 opted for bio-identical hormone replacement therapy to treat their menopausal symptoms in Turkey. However, side effects associated with bioidentical hormone treatment, such as weight loss, breast cancer, heart attacks, etc., hinder the market growth.
Innovations in bioidentical hormones by the key players are expected to create variety of opportunities for the market participants.
Market Segmentation
The Global Bioidentical Hormones Market is segmented further based on Type, Product Type, End-User, Distribution Channel, and Geography.
By Type, the market is classified into Estrogen, Progesterone, Testosterone, Combined Hormones, and others. Amongst all, the Estrogen segment is estimated to hold the highest market share during the forecast period.
By Product Type, the market is classified as tablets and capsules, creams and gels, injectables, patches and implants, and others. Amongst all, the tablets and capsules segment is estimated to hold the highest market share during the forecast period.
By End User, the market is classified as Hospital, Gynecology Clinics, Academics And Research, and Others. Amongst all, the Hospital segment is estimated to hold the highest market share during the forecast period.
By Distribution Channel, the market is classified as Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. Amongst all, the Retail Pharmacies segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. TherapeuticsMD and Theramex announced the approval of BIJUVE capsules indicated for hormone replacement therapy in the United Kingdom, under the trade name BIJUVA - 8th April 2021
2. Foresee Pharmaceuticals receives FDA approval of CAMCEVI, gonadotropin-releasing hormone (GnRH) agonist for the treatment of advanced prostate cancer - 26th May 2021
Company Profiles
Some of the companies covered in this report are Bayers AG, Biostation, BioTE Medical, Bravado Labs, Defy Medical LLC, etc.
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
Report Highlights:
Market Dynamics
The increasing government initiatives towards the health sector, the rising level of screening of hormonal deficiency, and growing healthcare expenditure have prompted the demand of the bioidentical hormones market. In addition, the increasing geriatric population, rising awareness, and focus on female healthcare have escalated the market growth. According to a study conducted by researchers from the Obstetrics and Gynaecology Department of Kafkas University in January 2019, nearly 432 females out of 926 opted for bio-identical hormone replacement therapy to treat their menopausal symptoms in Turkey. However, side effects associated with bioidentical hormone treatment, such as weight loss, breast cancer, heart attacks, etc., hinder the market growth.
Innovations in bioidentical hormones by the key players are expected to create variety of opportunities for the market participants.
Market Segmentation
The Global Bioidentical Hormones Market is segmented further based on Type, Product Type, End-User, Distribution Channel, and Geography.
By Type, the market is classified into Estrogen, Progesterone, Testosterone, Combined Hormones, and others. Amongst all, the Estrogen segment is estimated to hold the highest market share during the forecast period.
By Product Type, the market is classified as tablets and capsules, creams and gels, injectables, patches and implants, and others. Amongst all, the tablets and capsules segment is estimated to hold the highest market share during the forecast period.
By End User, the market is classified as Hospital, Gynecology Clinics, Academics And Research, and Others. Amongst all, the Hospital segment is estimated to hold the highest market share during the forecast period.
By Distribution Channel, the market is classified as Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. Amongst all, the Retail Pharmacies segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. TherapeuticsMD and Theramex announced the approval of BIJUVE capsules indicated for hormone replacement therapy in the United Kingdom, under the trade name BIJUVA - 8th April 2021
2. Foresee Pharmaceuticals receives FDA approval of CAMCEVI, gonadotropin-releasing hormone (GnRH) agonist for the treatment of advanced prostate cancer - 26th May 2021
Company Profiles
Some of the companies covered in this report are Bayers AG, Biostation, BioTE Medical, Bravado Labs, Defy Medical LLC, etc.
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Bioidentical Hormones Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the analyst’s positioning tool.
Report Highlights:
- A complete analysis of the market, including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Bioidentical Hormones Market
What is the estimated value of the Global Bioidentical Hormones Market?
What is the growth rate of the Global Bioidentical Hormones Market?
What is the forecasted size of the Global Bioidentical Hormones Market?
Who are the key companies in the Global Bioidentical Hormones Market?
Report Attribute | Details |
---|---|
No. of Pages | 182 |
Published | May 2021 |
Forecast Period | 2021 - 2026 |
Estimated Market Value ( USD
| USD 340.6 Million |
Forecasted Market Value ( USD
| USD 826.54 Million |
Compound Annual Growth Rate | 19.4% |
Regions Covered | Global |
No. of Companies Mentioned | 28 |
Table of Contents
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Influencers
5 Market Analysis
6 Global Bioidentical Hormones Market, By Type
7 Global Bioidentical Hormones Market, By Product
8 Global Bioidentical Hormones Market, By End Users
9 Global Bioidentical Hormones Market, By Distribution Channel
10 Global Bioidentical Hormones Market, By Geography
12 Company Profiles
13 Appendix
Companies Mentioned
- Allergan Inc
- Abbott Laboratories
- Actiza Pharmaceutical Private Limited
- Bayers AG
- The Biostation
- BioTE Medical
- Bravado Labs
- Defy Medical LLC
- GeneScience Pharmaceuticals Co. Ltd
- InMode Ltd
- Merck Group
- NextGenRx Compounding Pharmacy
- Novartis AG
- Noven Pharmaceuticals, Inc.
- Novo Nordisk A/S
- Nueva Aesthetic
- Papillon Medical
- Pellecome LLC
- Orion Pharma AB
- Pavilion Compounding Pharmacy, LLC
- Pellecome LLC
- Pfizer Inc
- Schwietermans Pharmacy
- SottoPelle
- Suprema HQ
- TherapeuticsMD Inc
- ZRT Laboratory
- United Pharmacy, LLC